Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    "Hemoglobin C disease"
Show Display Options
RSS Create an RSS feed from your search for:
"Hemoglobin C disease"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated
Has Results
Treatment of Sickle Cell Anemia With Stem Cell Transplant
Conditions: Sickle Cell Anemia;   Sickle Cell-hemoglobin C Disease;   Sickle Cell-β0-thalassemia
Interventions: Drug: Fludarabine;   Drug: Cytarabine;   Device: Cellular Infusions;   Radiation: Total Body Irradiation;   Drug: Cyclophosphamide;   Drug: Bortezomib;   Drug: Rituximab;   Procedure: Plasmapheresis
2 Withdrawn Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis
Conditions: Anemia, Sickle Cell;   Sickle Cell Anemia;   Sickle Cell Disease;   Sickle Cell Disorders;   Hemoglobin SC Disease;   Sickle Cell Hemoglobin C Disease
Interventions: Drug: MP4CO;   Drug: Sodium chloride solution
3 Completed Safety Study of MP4CO in Adult Sickle Cell Patients
Conditions: Anemia, Sickle Cell;   Sickle Cell Anemia;   Sickle Cell Disease;   Sickle Cell Disorders;   Hemoglobin SC Disease;   Sickle Cell Hemoglobin C Disease
Interventions: Drug: MP4CO;   Drug: Sodium chloride solution
4 Unknown  Far Infrared Radiation for Sickle Cell Pain Management
Condition: Anemia, Sickle Cell
Intervention: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
5 Completed
Has Results
Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies
Conditions: Hemoglobinopathies;   Sickle Cell Disease;   Thalassemia
Interventions: Drug: Busulfex;   Drug: Fludarabine;   Drug: Alemtuzumab;   Procedure: Stem Cell Transfusion

Indicates status has not been verified in more than two years